FDA inspection
Corden Pharma Colorado, Inc.: FDA inspection ending Nov 14, 2025
FDA inspection 1294814 · No Action Indicated (NAI) · Boulder, CO
Key facts
| Inspection ID | 1294814 |
|---|---|
| Firm | Corden Pharma Colorado, Inc. |
| FEI number | 1710165 |
| Address | 2075 55th St |
| City | Boulder |
| State | CO |
| ZIP | 80301 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Nov 14, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data